×

Methods for treating disorders associated with hyperlipidemia in a mammal

  • US 20070093468A1
  • Filed: 10/18/2006
  • Published: 04/26/2007
  • Est. Priority Date: 10/18/2005
  • Status: Abandoned Application
First Claim
Patent Images

1. A method of reducing at least one of (i) the concentration of cholesterol and/or triglycerides in the blood of a mammal, and (ii) the amount of a marker of atherosclerosis in a mammal, the method comprising administering each day to the mammal a combination of ezetimibe and BMS-201038, wherein BMS 201038 initially is administered at a first dosage in the range of 2.5 to 7.5 mg/day for at least 4 weeks, is then administered at a second dosage in the range of 5 to 10 mg/day for at least 4 weeks, and is then administered at a third dosage in the range of 7.5 to 12.5 mg/day for at least 4 weeks.

View all claims
  • 3 Assignments
Timeline View
Assignment View
    ×
    ×